The findings, published in the Neurology Clinical Practice journal, showed that the risk of Parkinson's was statistically ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

To validate the findings on Asians, researchers from the Seoul National University Hospital in South Korea examined 298,379 ...

Researchers have identified that G-quadruplexes promote harmful protein aggregation in neurodegenerative diseases. Blocking ...

After 6 months of DFP treatment, the AT genotype group displayed ... grant 2008 − 006842 − 25) and the French Parkinson's Disease Association. ApoPharma provided DFP formulations ...

A recently published study by researchers at the University of Arizona Health Sciences found that a tiny protein called PNA5 ...

AT THE MOMENT, the only FDA-approved stem cell treatment is a bone marrow transplant to treat blood diseases. The FDA has ...

Parkinson’s disease is a brain disorder that affects about one million people in the U.S. It happens when the brain loses ...

Parkinson’s disease is a progressive neurological condition that affects millions of people worldwide. While most treatments ...

The early phase presents a unique window for administering disease-modifying treatments sooner. ' Last night Katherine Fletcher, of Parkinson's UK, said: 'There is momentum gathering towards ways ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...